Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, Inborn

Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.

12,584 public trials 2,158 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, Inborn trial results

Active, not recruiting

Defining Endpoints in Becker Muscular Dystrophy

NCT05257473

Conditions
Becker Muscular Dystrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +10 more
Locations
  • University of California, Irvine Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View Trial Details
Active, not recruiting

An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

NCT07027527

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigational Site Darlinghurst, New South Wales, Australia
  • Investigational Site Kogarah, New South Wales, Australia
  • Investigational Site Westmead, New South Wales, Australia
  • Investigational Site Woolloongabba, Queensland, Australia
View all 20 locations
View Trial Details
Active, not recruiting

Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older

NCT06460506

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations
  • The Kids Research Institute Australia Nedlands, Australia
  • The Royal Children's Hospital Parkville, Australia
  • Queensland Children's Hospital South Brisbane, Australia
  • The Hospital for Sick Children Toronto, Canada
View all 18 locations
View Trial Details
Active, not recruiting

A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)

NCT04573023

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +16 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View all 25 locations
View Trial Details
Active, not recruiting

Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)

NCT04084080

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama Tuscaloosa, Alabama, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Howard University Center for Sickle Cell Disease Washington D.C., District of Columbia, United States
  • Emory University Atlanta, Georgia, United States
View all 23 locations
View Trial Details
Active, not recruiting

Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

NCT06433219

Conditions
Adnexal Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California San Francisco - UCSF Medical Center San Francisco, California, United States
  • Centricity Research Cancer Center - DBA CRRI John B. Amos Cancer Center Research Columbus, Georgia, United States
  • University of Chicago Comprehensive Cancer Center at Silver Cross - Carolyn J. Czerkies Pavilion Chicago, Illinois, United States
View all 84 locations
View Trial Details

Related conditions